M. De Lena

2.8k total citations
94 papers, 2.3k citations indexed

About

M. De Lena is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, M. De Lena has authored 94 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Oncology, 26 papers in Pulmonary and Respiratory Medicine and 20 papers in Pathology and Forensic Medicine. Recurrent topics in M. De Lena's work include Cancer Treatment and Pharmacology (20 papers), Lung Cancer Treatments and Mutations (18 papers) and Breast Cancer Treatment Studies (14 papers). M. De Lena is often cited by papers focused on Cancer Treatment and Pharmacology (20 papers), Lung Cancer Treatments and Mutations (18 papers) and Breast Cancer Treatment Studies (14 papers). M. De Lena collaborates with scholars based in Italy, United States and Spain. M. De Lena's co-authors include S. Monfardini, Gianni Bonadonna, Franca Fossati‐Bellani, G. Bonadonna, G. Beretta, Pinuccia Valagussa, Vito Lorusso, Angelo Paradiso, Michele Guida and Vito Lorusso and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and British Journal of Cancer.

In The Last Decade

M. De Lena

93 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. De Lena Italy 21 1.1k 554 546 474 448 94 2.3k
Lindsey Gumbrell United Kingdom 17 1.3k 1.1× 274 0.5× 932 1.7× 564 1.2× 392 0.9× 24 2.7k
J. L. Misset France 27 2.1k 1.9× 566 1.0× 433 0.8× 1.0k 2.2× 452 1.0× 63 3.0k
R B Weiss United States 20 1.1k 0.9× 242 0.4× 628 1.2× 465 1.0× 629 1.4× 37 2.5k
G. N. Hortobágyi United States 23 1.7k 1.5× 962 1.7× 573 1.0× 543 1.1× 154 0.3× 106 2.7k
Robert J. Belt United States 20 1.5k 1.3× 386 0.7× 789 1.4× 459 1.0× 133 0.3× 59 2.6k
Roberto Sorio Italy 26 1.7k 1.5× 533 1.0× 915 1.7× 560 1.2× 613 1.4× 129 3.6k
A Mittelman United States 26 1.3k 1.1× 197 0.4× 541 1.0× 642 1.4× 398 0.9× 104 2.6k
George P. Stathopoulos Greece 28 1.4k 1.2× 395 0.7× 689 1.3× 457 1.0× 235 0.5× 105 2.6k
Yasuyuki Kato Japan 27 605 0.5× 399 0.7× 924 1.7× 590 1.2× 583 1.3× 177 2.3k
Tate Thigpen United States 26 1.2k 1.0× 302 0.5× 493 0.9× 601 1.3× 754 1.7× 49 2.9k

Countries citing papers authored by M. De Lena

Since Specialization
Citations

This map shows the geographic impact of M. De Lena's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. De Lena with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. De Lena more than expected).

Fields of papers citing papers by M. De Lena

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. De Lena. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. De Lena. The network helps show where M. De Lena may publish in the future.

Co-authorship network of co-authors of M. De Lena

This figure shows the co-authorship network connecting the top 25 collaborators of M. De Lena. A scholar is included among the top collaborators of M. De Lena based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. De Lena. M. De Lena is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Placido, Sabino De, Michelino De Laurentiis, M. De Lena, et al.. (2005). A randomised factorial trial of sequential doxorubicin and CMF vs CMF and chemotherapy alone vs chemotherapy followed by goserelin plus tamoxifen as adjuvant treatment of node-positive breast cancer. British Journal of Cancer. 92(3). 467–474. 24 indexed citations
2.
Silvestris, Nicola, Modesto DʼAprile, Giovanna Andreola, et al.. (2004). Rationale for the use of gemcitabine in breast cancer (Review). International Journal of Oncology. 24(2). 389–98. 11 indexed citations
3.
Lena, M. De, Rodryg Ramlau, Olfred Hansen, et al.. (2004). Phase II trial of oral vinorelbine in combination with cisplatin followed by consolidation therapy with oral vinorelbine in advanced NSCLC. Lung Cancer. 48(1). 129–135. 25 indexed citations
4.
Lorusso, Vito, E. Crucitta, N. Panza, et al.. (2002). Phase I/II study of paclitaxel, gemcitabine and vinorelbine as first-line chemotherapy of non-small-cell lung cancer. Annals of Oncology. 13(12). 1862–1867. 4 indexed citations
5.
Paradiso, Angelo, Girolamo Ranieri, Nicola Silvestris, et al.. (2001). Failure of primary breast cancer neoangiogenesis to predict pattern of distant metastasis. Clinical and Experimental Medicine. 1(3). 127–132. 5 indexed citations
6.
Paradiso, Angelo, G. Simone, M. De Lena, et al.. (2001). Expression of apoptosis-related markers and clinical outcome in patients with advanced colorectal cancer. British Journal of Cancer. 84(5). 651–658. 29 indexed citations
7.
Lena, M. De, et al.. (2000). High Efficacy of Paclitaxel and Doxorubicin as First-Line Therapy in Advanced Breast Cancer: A Phase I-II Study. Journal of Chemotherapy. 12(4). 367–373. 4 indexed citations
8.
Paradiso, Angelo, G. Simone, B Leone, et al.. (2000). Thymidilate synthase and p53 primary tumour expression as predictive factors for advanced colorectal cancer patients. British Journal of Cancer. 82(3). 560–567. 122 indexed citations
9.
Lorusso, Vito, C. F. Pollera, Mauro Antimi, et al.. (1998). A phase II study of gemcitabine in patients with transitional cell carcinoma of the urinary tract previously treated with platinum. European Journal of Cancer. 34(8). 1208–1212. 242 indexed citations
10.
Lena, M. De, Vito Lorusso, Mario Brandi, et al.. (1997). Revertant and potentiating activity of lonidamine in patients with ovarian cancer previously treated with platinum.. Journal of Clinical Oncology. 15(10). 3208–3213. 28 indexed citations
11.
Lorusso, Vito, Arcangelo Pagliarulo, Francesco Paolo Selvaggi, et al.. (1996). Treatment of Advanced Urothelial Carcinoma with M-VECA (Methotrexate, Vinblastine, Epirubicin and Carboplatin). Journal of Chemotherapy. 8(2). 154–158. 4 indexed citations
12.
Paradiso, Angelo, Anita Mangia, Saverio Fusilli, et al.. (1995). Heterogeneity of intratumour proliferative activity in primary breast cancer: Biological and clinical aspects. European Journal of Cancer. 31(6). 911–916. 17 indexed citations
13.
Lena, M. De, A. Romero, Mario Rabinovich, et al.. (1993). Metastatic Pattern and DNA Ploidy in Stage IV Breast Cancer at Initial Diagnosis. American Journal of Clinical Oncology. 16(3). 245–249. 6 indexed citations
14.
Correale, M., Angelo Paradiso, Ines Abbate, et al.. (1993). Cytosolic Levels of Estrogen-Regulated pS2 Protein in Breast Cancer: Correlation with Tumor Proliferative Activity. Tumor Biology. 14(1). 30–37. 6 indexed citations
15.
Paradiso, Angelo, Vito Lorusso, Stefania Tommasi, et al.. (1988). Relevance of cell kinetics to hormonal response of receptor-positive advanced breast cancer. Breast Cancer Research and Treatment. 11(1). 31–36. 14 indexed citations
16.
Brambilla, Cristina, M. De Lena, Anna Rossi, Pinuccia Valagussa, & Gianni Bonadonna. (1976). Response and survival in advanced breast cancer after two non-cross-resistant combinations.. BMJ. 1(6013). 801–804. 98 indexed citations
17.
Bonadonna, Gianni, M. De Lena, A Lattuada, et al.. (1975). Combination chemotherapy and radiotherapy in non-Hodgkin's lymphomata.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 2. 481–8. 15 indexed citations
18.
Lena, M. De. (1975). Antineoplastic and Immunosuppressive Agents.. Tumori Journal. 61(5). 497–497. 89 indexed citations
19.
Lena, M. De, et al.. (1970). Sperimentazione clinica con alte dosi intermittenti di methotrexate nel carcinoma oro-faringeo in fase avanzata.. Tumori. 56(5). 259–268. 2 indexed citations
20.
Bonadonna, Gianni, S. Monfardini, M. De Lena, & Franca Fossati‐Bellani. (1969). Clinical Evaluation of Adriamycin, a New Antitumour Antibiotic. BMJ. 3(5669). 503–506. 174 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lindsey Gumbrell Breakdown of academic impact, for papers by J. L. Misset Breakdown of academic impact, for papers by R B Weiss Breakdown of academic impact, for papers by G. N. Hortobágyi Breakdown of academic impact, for papers by Robert J. Belt Breakdown of academic impact, for papers by Roberto Sorio Breakdown of academic impact, for papers by A Mittelman Breakdown of academic impact, for papers by George P. Stathopoulos Breakdown of academic impact, for papers by Yasuyuki Kato Breakdown of academic impact, for papers by Tate Thigpen
Rankless by CCL
2026